Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: Updated survival results of the randomized, phase 3 study DESTINY-Breast03Sara Hurvitz,Roberto Hegg,Wei-Pang Chung,Seock-Ah Im,William Jacot,Vinod Ganju,Joanne Win Yang Chiu,Binghe Xu,Erika Hamilton,Srinivasan Madhusudan,Hiroji Iwata,Sevilay Altintas,Jan-Willem Henning,Giuseppe Curigliano,Jose Manuel Perez-Garcia,Anton Egorov, Yali Liu,Jillian Cathcart, Shahid Ashfaque,Javier CortesCANCER RESEARCH（2023）引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
